Huron (HURN) Q2 EPS Jumps 12.5%

Huron Consulting Group (HURN) reported strong Q2 FY2025 adjusted results, with adjusted diluted EPS of $1.89 surpassing estimates by $0.10 and revenue growing 8.3% to $402.5 million, largely in line with expectations. Despite a GAAP net income decline due to a one-time impairment, the underlying business demonstrated robust growth across its Healthcare, Education, and Digital segments, driven by increased consultant utilization and strategic acquisitions. Reflecting this operational strength, management raised its full-year revenue and adjusted EPS guidance, underscoring confidence in its core markets and strategic initiatives.

Analysis

Huron Consulting Group (HURN) reported a bifurcated second-quarter performance, where strong underlying operational results overshadowed a significant decline in GAAP net income. The company surpassed non-GAAP EPS estimates by $0.10, delivering $1.89 per share, a 12.5% year-over-year increase, while revenue grew 8.3% to $402.5 million. The substantial 48.3% drop in GAAP net income was directly attributable to a non-recurring $8.2 million after-tax investment impairment and the non-recurrence of an $11.1 million litigation gain from the prior year, making the adjusted figures a more accurate representation of core business health. Operational efficiency improved, evidenced by an 8.8% rise in adjusted EBITDA to $60.6 million and a 3.3 percentage point increase in consultant utilization to 77.0%. Segment performance was led by a 28.2% surge in the Commercial segment, primarily fueled by the AXIA Consulting acquisition, though traditional consulting within this segment declined. The core Healthcare and Education segments posted solid growth of 4.1% and 5.3%, respectively. Critically, management raised its full-year guidance for both revenue and adjusted EPS, signaling strong confidence in sustained demand from its key markets and successful integration of strategic initiatives. The company's aggressive capital return, repurchasing 5.3% of shares outstanding in the first six months of 2025, further underscores this positive outlook.

Key Decisions for Investors

• Investors should focus on the strong operational metrics and the significant upward revision of full-year guidance for revenue and adjusted EPS, treating the GAAP net income decline as a non-operational, one-time event.
• Monitor the organic growth within the Commercial segment to ensure the AXIA acquisition successfully masks underlying weakness in traditional consulting, and watch for continued strength in consultant utilization rates as a key driver of margin expansion.
• The aggressive share repurchase program provides a strong signal of management's confidence and offers direct support to the share price, while the newly expanded $1.1 billion credit facility positions the company for further accretive M&A.
• Consider the noted decline in Healthcare digital services demand as a potential risk factor, warranting close attention in subsequent quarters for signs of broader client budget constraints in this key vertical.